Tag: Global Healthcare Award

Seo-Eun Choi | Medicine and Dentistry | Best Researcher Award

Published on by Shen Awards

Dr. Seo-Eun Choi | Medicine and Dentistry | Best Researcher Award

University of Washington, United States

Dr. Seo-Eun Choi is a distinguished Senior Research Scientist at the University of Washington, specializing in statistical applications in biomedical research, particularly Alzheimer’s disease and cognitive studies. She holds a Ph.D. in Statistics from Florida State University, an M.S. in Statistics from the University of Michigan – Ann Arbor, and a B.S. in Statistics with a minor in Computer Science from Ewha Womans University, South Korea. Over her career, Dr. Choi has developed deep expertise in Bayesian modeling, model selection, categorical and multivariate data analysis, spatio-temporal modeling, psychometrics, and neuroimaging data analysis. She has led and contributed to numerous international and interdisciplinary research projects, producing a strong publication record of 96 documents with 728 citations and an h-index of 12, highlighting her influence in both statistical methodology and clinical applications. Her research skills include advanced statistical computing, data visualization, and application of complex statistical models to large-scale neuroimaging and clinical datasets. Dr. Choi is an active member of the Alzheimer’s Association International Society to Advance Alzheimer’s Research and Treatment (ISTAART) and the American Statistical Association (ASA), reflecting her engagement with the broader scientific community and commitment to advancing collaborative research initiatives. Her contributions have been recognized through multiple awards and honors for excellence in statistical research, interdisciplinary collaboration, and mentorship, demonstrating her leadership and impact on the field. Looking forward, Dr. Choi’s work has significant potential to advance high-impact publications in Q1 journals, expand global collaborations, and provide mentorship to emerging researchers, thereby influencing both methodological innovation and practical applications in neurodegenerative disease research. Her combination of expertise, experience, and dedication makes her an exemplary candidate for recognition, reflecting outstanding contributions to science, research leadership, and societal impact in the field of biostatistics and neuroscience.

Profile: Google Scholar

Featured Publications

  1. Jutten, R. J., Grandoit, E., Foldi, N. S., Sikkes, S. A. M., Jones, R. N., Choi, S. E., … et al. (2020). Lower practice effects as a marker of cognitive performance and dementia risk: A literature review. Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, 12(1), 1–12.

  2. Mukherjee, S., Mez, J., Trittschuh, E. H., Saykin, A. J., Gibbons, L. E., Fardo, D. W., … et al. (2020). Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups. Molecular Psychiatry, 25(11), 2942–2951.

  3. Choi, S. E., Mukherjee, S., Gibbons, L. E., Sanders, R. E., Jones, R. N., Tommet, D., … et al. (2020). Development and validation of language and visuospatial composite scores in ADNI. Alzheimer’s & Dementia: Translational Research & Clinical Interventions, 6(1), e12024.

  4. Eissman, J. M., Dumitrescu, L., Mahoney, E. R., Smith, A. N., Mukherjee, S., Lee, M. L., … et al. (2022). Sex differences in the genetic architecture of cognitive resilience to Alzheimer’s disease. Brain, 145(7), 2541–2554.

  5. Mukherjee, S., Choi, S. E., Lee, M. L., Scollard, P., Trittschuh, E. H., Mez, J., … et al. (2020). Cognitive domain harmonization and co-calibration in studies of older adults. Neuropsychology, 37(4), 409–423.

Waseem AlZamzami | Medicine and Dentistry | Best Researcher Award

Published on by Shen Awards

Assoc. Prof. Dr. Waseem AlZamzami | Medicine and Dentistry | Best Researcher Award

University of Tabuk, Saudi Arabia

Assoc. Prof. Dr. Waseem A. AlZamzami is an accomplished researcher and academic in hematopathology, molecular hematology, and cancer biology, with a strong focus on genomics, transcriptomics, metabolomics, and bioinformatics. He earned his Ph.D. in Clinical Laboratory Science from The Catholic University of America, Washington DC (2015–2022), following an M.S. in Health Sciences from Quinnipiac University, Connecticut (2013–2015), and a B.Sc. in Laboratory Medicine from Umm Al-Qurra University, Saudi Arabia (2002–2006). His professional journey includes extensive research training at the National Cancer Institute/National Institutes of Health (NCI/NIH), Bethesda, USA, where he contributed to advancing cancer genetics and translational hematology. Currently serving as an Assistant Professor of Hematology at the University of Tabuk, Saudi Arabia, he has held multiple leadership roles such as Committee Chairman for Laboratory Management, Unit Chairman for Measurement and Evaluation, and active member of Accreditation, Quality Assurance, and Curriculum Development committees. His research interests center on genetic screening, biomarker discovery, and integration of multi-omics to drive precision oncology and personalized treatment strategies. Dr. AlZamzami has authored publications in reputed journals including Discovery Medicine, Molecular Syndromology, PLOS ONE, and Cancers, with a Scopus record of 9 documents, 36 citations, and an h-index of 3, alongside three recent Saudi patents in hematological malignancies and cancer genomics. He is also a dedicated reviewer for journals such as PLOS ONE, Process Biochemistry, and International Immunopharmacology. His research skills span molecular diagnostics, bioinformatics, laboratory medicine, multi-omics analysis, and translational applications bridging bench to bedside. Recognized through international symposium presentations at NIH and national scientific forums, he has also contributed to scientific community development by mentoring students and organizing academic events. In conclusion, Dr. Waseem A. AlZamzami exemplifies a distinguished researcher whose academic excellence, innovative research, and leadership contributions to cancer biology and hematology strongly position him as a driving force in advancing precision medicine and biomedical research globally.

Profile: Scopus |ORCID| Google Scholar

Featured Publications

  1. Yan, H., Malik, N., Kim, Y. I., He, Y., Li, M., Dubois, W., Liu, H., Peat, T. J., Nguyen, J. T., … (2021). Fatty acid oxidation is required for embryonic stem cell survival during metabolic stress. EMBO Reports, 22(6), e52122.

  2. Oyouni, A. A. A., Al-Amer, O. M., Ali, F. A. Z., Altayar, M. A., Jalal, M. M., Albalawi, R. S. M., … (2022). Melatonin ameliorates the adrenal and pancreatic alterations in streptozotocin-induced diabetic rats: Clinical, biochemical, and descriptive histopathological studies. Frontiers in Veterinary Science, 9, 1016312.

  3. Seshadri, V. D., Oyouni, A. A. A., Hawsawi, Y. M., Aljohani, S. A. S., Al-Amer, O. M., … (2022). Chemopreventive role of Tin oxide–Chitosan–Polyethylene glycol–Crocin nanocomposites against lung cancer: An in vitro and in vivo approach. Process Biochemistry, 120, 186–194.

  4. Al-Amer, O. M., Mir, R., Hamadi, A., Alasseiri, M. I., Altayar, M. A., AlZamzami, W., … (2023). Antiapoptotic gene genotype and allele variations and the risk of lymphoma. Cancers, 15(4), 1012.

  5. Vijayaragavan, P., Rathi, M. A., Gopalakrishnan, V. K., Pashameah, R. A., … (2022). CpG methylation analysis of tumour suppressor gene and expression of cathepsin B in renal cell carcinoma. Journal of King Saud University – Science, 34(8), 102330.

Xingwang Yao | Health Professions | Best Researcher Award

Published on by Shen Awards

Assoc. Prof. Dr. Xingwang Yao | Health Professions | Best Researcher Award

The Second Xiangya Hospital (Central South University, China) | China

Dr. Yao Xingwang is a senior nurse and accomplished clinical researcher at the Operating Department, Xiangya Second Hospital, Central South University, China. With a strong background in clinical nursing, patient care, and interdisciplinary medical research, he has established himself as a leading figure in the integration of nursing practice with scientific innovation. His professional journey reflects dedication to enhancing the quality of healthcare services through advanced nursing strategies, patient-centered interventions, and translational research. Dr. Yao has actively contributed to the development of innovative treatment methods, clinical nursing guidelines, and healthcare technologies that improve patient outcomes in complex medical conditions. He has also played a key role in research projects funded by provincial and institutional bodies, focusing on areas such as cancer therapy, cardiovascular health, chronic disease management, and perioperative nursing care. Beyond clinical practice and research, Dr. Yao has contributed to academic literature through peer-reviewed journal articles, patents, and textbooks. His ability to bridge the gap between evidence-based nursing and real-world clinical application makes him a highly respected professional in his field. Dr. Yao’s leadership, innovation, and scholarly contributions position him as a distinguished candidate for recognition in international research awards.

Professional Profile

Education

Dr. Yao Xingwang pursued his academic journey at Central South University, one of China’s leading institutions in nursing education and medical sciences. He obtained a Bachelor of Science in Nursing, which laid the foundation for his clinical expertise and patient-centered approach in healthcare. Building upon this, he completed his Master of Science in Nursing under the supervision of esteemed faculty, where he deepened his understanding of advanced nursing practices, clinical interventions, and evidence-based care models. Throughout his education, Dr. Yao developed strong research skills, participating in academic projects that explored the intersections of nursing care and biomedical sciences. His postgraduate studies enabled him to contribute to multidisciplinary research teams, enriching his clinical knowledge with a solid research background. His academic foundation not only provided him with technical expertise but also instilled in him the values of professionalism, compassion, and scientific inquiry. This balance of clinical knowledge and academic training shaped him into a professional capable of leading complex nursing projects and conducting impactful clinical studies. His educational background has been the cornerstone of his career success, empowering him to blend theoretical knowledge with practical applications in the advancement of nursing science and patient care.

Professional Experience

Dr. Yao Xingwang has built an extensive professional career at the Operating Department, Xiangya Second Hospital, Central South University, where he has served in various capacities with increasing responsibility. His early experience as a clinical nurse provided him with hands-on expertise in perioperative care, surgical assistance, patient monitoring, and emergency response. Through dedication and continuous professional development, he advanced to the role of senior nurse, where he has been responsible for supervising clinical teams, ensuring adherence to nursing protocols, and implementing high standards of patient safety and care quality. In addition to his clinical responsibilities, Dr. Yao has been deeply engaged in medical research projects, serving as both a principal investigator and key member in studies supported by provincial foundations and health commissions. His professional experience extends to academic contributions, including publishing in high-impact journals and contributing to textbooks on nursing management and clinical practices. He has also been active in developing innovative healthcare devices, holding patents that address practical clinical challenges. Dr. Yao’s career reflects a seamless integration of nursing service, research innovation, and leadership, making him a role model for aspiring nursing professionals and a respected figure in the field of healthcare.

Research Interest

Dr. Yao Xingwang’s research interests lie at the intersection of nursing science, medical innovation, and patient-centered care. His work focuses on clinical nursing quality evaluation, mindfulness-based interventions for patients with chronic conditions, and the development of evidence-based nursing protocols to improve treatment outcomes. He has contributed significantly to research in cancer therapy, investigating the role of autophagy in cancer stem cell treatment and advancing photodynamic therapy strategies. In cardiovascular nursing, his studies have explored the mechanisms of myocardial injury and interventions that can reduce patient mortality and morbidity. Additionally, Dr. Yao has shown keen interest in mental health within nursing practice, leading projects that examine the impact of mindfulness therapy on depression, anxiety, and cognitive function in elderly diabetic patients. His research also extends to the development of clinical tools and devices, with patents addressing surgical and postoperative care needs. A common theme across his research is the integration of advanced biomedical insights with nursing interventions, ensuring that scientific advancements translate into tangible improvements in patient care. Dr. Yao’s research interests not only address pressing healthcare challenges but also reflect a vision of holistic, evidence-based nursing practice with global impact.

Research Skills

Dr. Yao Xingwang possesses a comprehensive set of research skills that complement his clinical expertise and enable him to conduct high-impact studies in nursing and healthcare. He is proficient in clinical trial design, data collection, and statistical analysis, allowing him to evaluate the effectiveness of nursing interventions with precision. His skills in laboratory techniques support his involvement in biomedical research projects, particularly in cancer biology and cardiovascular studies. Dr. Yao is experienced in the use of advanced imaging tools, including magnetic resonance imaging, for clinical research purposes. He is also skilled in qualitative and quantitative research methodologies, enabling him to address both patient experiences and measurable clinical outcomes. Beyond technical skills, Dr. Yao demonstrates strong project management capabilities, having successfully coordinated multidisciplinary research teams and contributed to projects funded by major provincial and institutional bodies. His ability to translate research findings into practical nursing protocols showcases his applied research strength. Furthermore, his editorial and textbook contributions reflect his academic writing and scientific communication skills. Collectively, these skills underscore his capacity to bridge clinical practice with rigorous research, positioning him as a versatile researcher dedicated to improving patient outcomes through evidence-based nursing innovations.

Awards and Honors

Dr. Yao Xingwang has earned recognition through his contributions to nursing research, clinical practice, and innovation. His scholarly achievements include publications in esteemed journals such as the International Journal of Molecular Medicine, FASEB Journal, and Medicine (Baltimore), where his work has advanced understanding in areas of degenerative disease, cancer biology, and clinical interventions. His role as co-first author and corresponding author in several papers highlights his leadership and intellectual contributions to collaborative research. Dr. Yao has also been honored for his innovation in healthcare technologies, holding utility model patents for devices such as adjustable pancreatic juice diversion systems, multifunctional operating bed covers, and specialized drainage devices for cardiac surgery. These patents demonstrate his ability to identify clinical challenges and provide practical, patient-focused solutions. Additionally, his editorial contributions as compiler and deputy editor of nursing and clinical surgery textbooks reflect recognition of his academic expertise and teaching value. These honors underscore his influence in shaping nursing knowledge, advancing clinical practice, and fostering healthcare innovation. Collectively, Dr. Yao’s awards and honors showcase a career defined by excellence, leadership, and impactful contributions to both academic research and clinical nursing practice.

Publication Top Notes

  • FOXO3-Activated circFGFBP1 Inhibits Extracellular Matrix Degradation and Nucleus Pulposus Cell Death via miR-9-5p/BMP2 Axis in Intervertebral Disc Degeneration In Vivo and In Vitro — 2023 — 2 citations

Conclusion

In conclusion, Dr. Yao Xingwang exemplifies the qualities of a distinguished nurse researcher, clinician, and innovator. His career has been marked by an exceptional combination of hands-on nursing excellence, groundbreaking research contributions, and dedication to improving healthcare outcomes. By bridging clinical nursing with advanced biomedical research, he has advanced patient care in oncology, cardiovascular health, chronic disease management, and mental health interventions. His patents and publications stand as evidence of his innovative spirit and scholarly productivity, while his editorial work reflects a commitment to knowledge dissemination and professional education. Dr. Yao’s leadership in clinical projects, combined with his patient-centered approach, highlights his ability to influence both practice and policy within nursing science. With a proven track record of success and a clear vision for future contributions, he is well-positioned to expand his global collaborations, publish in leading international journals, and assume greater leadership roles in the academic and healthcare communities. Dr. Yao’s achievements and potential make him not only deserving of recognition but also an inspiring role model for the next generation of nursing professionals committed to advancing science and society.

Willi Tarver | Medicine and Dentistry | Best Researcher Award

Published on by Shen Awards

Dr. Willi Tarver | Medicine and Dentistry | Best Researcher Award

Assistant Professor from The Ohio State University, United States

Dr. Willi L. Tarver is a distinguished Assistant Professor in the Division of Cancer Prevention and Control at The Ohio State University, where he leverages his interdisciplinary expertise to address disparities in healthcare delivery and cancer outcomes. With a strong foundation in public health informatics, behavioral oncology, and medical library sciences, Dr. Tarver’s research focuses on integrating patient-reported outcomes (PROs), electronic tools, and equity-focused interventions to better engage underserved populations in the cancer care continuum. His professional trajectory includes advanced fellowships in behavioral oncology and medical informatics, and he is actively involved in federally funded research projects. Dr. Tarver is also deeply committed to mentoring students and early-career professionals, especially from underrepresented backgrounds. His scholarly work addresses systemic issues in healthcare access and aims to develop scalable, tech-based strategies to reduce disparities. In addition to research and teaching, he plays key roles in administrative and clinical improvement initiatives within OSU’s Quality Improvement Hub. Dr. Tarver’s growing leadership within national organizations, innovative approach to equitable cancer prevention, and consistent focus on translating research into real-world applications position him as a leader in academic medicine and public health. He is a compelling nominee for the Best Researcher Award.

Professional Profile

Education

Dr. Tarver’s educational background reflects a unique and valuable combination of public health, information science, and communication, which together form the backbone of his interdisciplinary research. He earned his Doctor of Public Health (Dr.P.H.) from the University of Alabama at Birmingham, where he was also a recipient of the prestigious NCI Diversity Supplement under the Cancer Prevention and Control Training Program. Prior to this, he completed dual Master’s degrees in Public Health (MPH) and Library and Information Science (MLIS) at the University of South Florida. His foundational undergraduate training includes a B.A. in Communication from Columbus State University and an A.S. in Pre-Pharmacy from Gordon College. Dr. Tarver further sharpened his expertise through two postdoctoral fellowships: one in Behavioral Oncology at Indiana University and another in Medical Informatics at the VA Medical Center in Indianapolis. These fellowships provided him with advanced training in clinical research, data analytics, and healthcare system improvement. His broad and deep academic background allows him to bridge clinical research, informatics, and patient-centered interventions—a combination that has enabled his innovative work in cancer disparities and technology-enhanced health solutions.

Professional Experience

Dr. Tarver’s professional journey is defined by a blend of academic, clinical, and administrative roles that support his contributions to cancer prevention, health equity, and public health informatics. Currently serving as an Assistant Professor in the Division of Cancer Prevention and Control within the Department of Internal Medicine at The Ohio State University, he has held this role since 2019. Prior to this appointment, he was a postdoctoral and informatics fellow at the Roudebush VA Medical Center and Indiana University–Purdue University Indianapolis. During his time at the VA, Dr. Tarver contributed to the Center for Health Information and Communication, refining his expertise in applying informatics to support equitable healthcare delivery. His professional roles also extend into quality improvement, where he co-led the Health Equity Core at OSU’s Quality Improvement Hub from 2022 to 2024. Dr. Tarver is an active mentor in OSU’s Center for Cancer Health Equity Summer Research Program, guiding underrepresented students in impactful, community-focused projects. In addition, he participates in institutional governance as a member of OSU’s Innovation Council. Across his roles, he has demonstrated consistent leadership, interdisciplinary collaboration, and a deep commitment to improving health outcomes through equitable and data-driven approaches.

Research Interests

Dr. Tarver’s research is driven by a deep commitment to eliminating disparities in cancer prevention and control through the integration of technology, public health, and clinical practice. His primary interest lies in the development and evaluation of patient-centered technologies—particularly electronic patient-reported outcomes (ePRO) tools—to better engage underserved populations and inform health system decision-making. His projects explore how these tools can be tailored to the unique needs of minority communities, improve cancer survivorship planning, and enhance real-time communication between patients and providers. Another major area of interest is health equity, where Dr. Tarver investigates the impact of perceived discrimination, systemic biases, and cultural barriers on cancer care utilization and outcomes. Additionally, he is involved in research that evaluates educational interventions designed to reduce STEM-related biases in high school learning environments. Through his interdisciplinary work, Dr. Tarver aims to generate actionable insights that not only contribute to academic knowledge but also guide policy reforms and clinical practices. His interests span behavioral oncology, implementation science, and medical informatics, positioning him at the forefront of translational research that impacts patient lives while advancing health equity on a systemic scale.

Research Skills

Dr. Tarver possesses a robust skill set in both qualitative and quantitative research methodologies, which he applies to projects at the intersection of health equity, informatics, and cancer prevention. He is highly experienced in designing and analyzing patient-reported outcomes (PROs), particularly within underserved and minority populations. His expertise includes conducting structured interviews, participant observation, and systematic reviews—skills he actively shares as a guest lecturer in OSU’s Public Health Informatics course. Dr. Tarver is also proficient in research related to intervention development and evaluation, including randomized trials and implementation science frameworks. His grant-writing capabilities are demonstrated by his role as Principal Investigator (PI) and Co-Investigator (Co-I) on several federal and institutional research awards. He collaborates across disciplines, including clinical medicine, education, behavioral science, and information systems, to build comprehensive research designs. Additionally, he has applied informatics tools for data visualization, regulatory decision-making, and game-based learning assessments. These skills empower him to execute complex, multilevel projects with real-world applicability and high translational value. His research toolkit is complemented by strong mentorship abilities, fostering new talent and promoting equity-focused research within academic and clinical settings.

Awards and Honors

Dr. Tarver has received multiple prestigious honors that reflect his academic excellence, research promise, and commitment to advancing health equity. He was honored with the Young Investigator Award at the VA Medical Center in Indianapolis, recognizing his early-career contributions to cancer prevention research. His selection for the VA Advanced Fellowship in Medical Informatics further highlights his potential as a leader in data-driven health solutions. As a fellow in Behavioral Oncology at Indiana University, he gained national recognition for his work integrating psychological, behavioral, and technological approaches to patient-centered care. Notably, he was a recipient of the Diversity Supplement from the National Cancer Institute (NCI) through the University of Alabama at Birmingham, affirming his focus on minority health and health disparities. Earlier in his academic journey, he was awarded the ALSTARS Scholarship at the University of South Florida for academic merit and leadership. These accolades not only reflect his dedication to research excellence but also underscore the national recognition he has received for addressing some of the most pressing challenges in health equity, cancer care, and public health education.

Conclusion

In conclusion, Dr. Willi L. Tarver stands out as an exceptionally well-rounded and impactful academic professional whose contributions significantly advance the fields of cancer prevention, public health informatics, and health equity. His ability to bridge research, mentorship, education, and clinical innovation uniquely qualifies him for the Best Researcher Award. Through interdisciplinary training, funded research projects, and active mentorship, Dr. Tarver continues to address real-world health disparities and improve patient outcomes, particularly in underserved communities. His track record as a Principal Investigator and collaborator on diverse research grants highlights his leadership and collaborative capabilities. Moreover, his mentorship of minority students and involvement in institutional quality improvement initiatives reflect a long-term investment in both people and systems. With a growing portfolio of honors, active society memberships, and educational contributions, Dr. Tarver is positioned for continued excellence and recognition in the academic and public health communities. His work exemplifies the values of translational research, social impact, and scientific integrity, making him a deserving and distinguished candidate for the Best Researcher Award.

Publications Top Notes

1. Family structure and risk behaviors: the role of the family meal in assessing likelihood of adolescent risk behaviors
📅 Year: 2014
✍️ Authors: S. Goldfarb, W.L. Tarver, B. Sen
📰 Psychology Research and Behavior Management, pp. 53–66
📈 Citations: 83

2. The use of cancer-specific patient-centered technologies among underserved populations in the United States: systematic review
📅 Year: 2019
✍️ Authors: W.L. Tarver, D.A. Haggstrom
📰 Journal of Medical Internet Research, 21(4), e10256
📈 Citations: 68

3. Growth dynamics of patient-provider internet communication: trend analysis using the Health Information National Trends Survey (2003 to 2013)
📅 Year: 2018
✍️ Authors: W.L. Tarver, T. Menser, B.W. Hesse, T.J. Johnson, E. Beckjord, E.W. Ford, et al.
📰 Journal of Medical Internet Research, 20(3), e109
📈 Citations: 56

4. A systematic review of the association between family meals and adolescent risk outcomes
📅 Year: 2015
✍️ Authors: S.S. Goldfarb, W.L. Tarver, J.L. Locher, J. Preskitt, B. Sen
📰 Journal of Adolescence, 44, pp. 134–149
📈 Citations: 56

5. Exploring disparities and variability in perceptions and self-reported colorectal cancer screening among three ethnic subgroups of US Blacks
📅 Year: 2010
✍️ Authors: C.K. Gwede, C.M. William, K.B. Thomas, W.L. Tarver, G.P. Quinn, et al.
📰 Oncology Nursing Forum, 37(5), 581
📈 Citations: 51

6. A randomized trial to compare a tailored web-based intervention and tailored phone counseling to usual care for increasing colorectal cancer screening
📅 Year: 2018
✍️ Authors: V.L. Champion, S.M. Christy, W. Rakowski, W.G. Gathirua-Mwangi, W.L. Tarver, et al.
📰 Cancer Epidemiology, Biomarkers & Prevention, 27(12), 1433–1441
📈 Citations: 35

7. The impact of health information technology on cancer care across the continuum: a systematic review and meta-analysis
📅 Year: 2016
✍️ Authors: W.L. Tarver, N. Menachemi
📰 Journal of the American Medical Informatics Association, 23(2), 420–427
📈 Citations: 35

8. Perceptions of colorectal cancer among three ethnic subgroups of US blacks: a qualitative study
📅 Year: 2011
✍️ Authors: C.K. Gwede, E. Jean-Francois, G.P. Quinn, S. Wilson, W.L. Tarver, K.B. Thomas, et al.
📰 Journal of the National Medical Association, 103(8), 669–680
📈 Citations: 35

9. Allostatic load: a framework to understand breast cancer outcomes in Black women
📅 Year: 2021
✍️ Authors: S. Obeng-Gyasi, W. Tarver, R.C. Carlos, B.L. Andersen
📰 NPJ Breast Cancer, 7(1), 100
📈 Citations: 34

10. Factors associated with adherence to mammography screening among insured women differ by income levels
📅 Year: 2018
✍️ Authors: W. Gathirua-Mwangi, A. Cohee, W.L. Tarver, A. Marley, E. Biederman, et al.
📰 Women’s Health Issues, 28(5), 462–469
📈 Citations: 34

Xia Chen | Medicine and Dentistry | Best Researcher Award

Published on by Shen Awards

Ms. Xia Chen | Medicine and Dentistry |  Best Researcher Award

Professor from Yunnan Provincial Hospital of Chinese Medicine, China

Xia Chen is an accomplished chief physician, professor, and master’s supervisor, specializing in integrated Chinese and Western medicine, particularly in gastroenterology. Born in 1978 in Yunnan, China, she has devoted more than two decades to clinical practice, teaching, and scientific research. Currently, she serves as the leader of the Department of Gastroenterology of Traditional Chinese Medicine at Yunnan Provincial Hospital of Chinese Medicine. She has gained recognition as an Outstanding Young Practitioner of Chinese Medicine in Yunnan Province and holds membership in the Hepatobiliary Disease Branch of the Chinese Medical Association. Her career focuses on the diagnosis and treatment of digestive diseases using both traditional Chinese medicine and Western medicine approaches. Xia Chen’s contribution extends beyond clinical work to research projects, drug trials, and academic publishing. Her ability to bridge traditional and modern medical practices has made her a notable figure in her field. Over the years, she has led and participated in numerous prestigious research projects and has authored or co-authored several scholarly works. Xia Chen’s career reflects dedication to improving healthcare outcomes through integrated medicine and advancing research in digestive health, making her a leader in her specialty and an inspiration for future researchers and clinicians.

Professional Profile

Education

Although detailed information about Xia Chen’s educational background is not explicitly provided, her current standing as a chief physician and professor suggests a comprehensive academic journey in medicine, likely beginning with a bachelor’s degree in traditional Chinese medicine or clinical medicine. Following her undergraduate studies, it is plausible she pursued further specialization, completing advanced degrees, possibly a master’s degree or doctorate, focusing on integrated Chinese and Western medicine with a specialty in digestive diseases. Xia Chen’s position as a master’s supervisor also indicates her formal academic qualification aligns with national standards for academic leadership roles in China, which typically require at least a master’s degree combined with significant clinical expertise. Her education would have provided her a strong foundation in traditional Chinese medical principles, combined with extensive training in modern clinical practices, pharmacology, and research methodology. Given her leadership in research projects and teaching, she likely continued her professional development through certifications, clinical fellowships, and continuous medical education programs. Her educational journey underpins her expertise in gastroenterology and serves as the backbone for her clinical, academic, and research excellence.

Professional Experience

Xia Chen has built a remarkable professional career, accumulating over 20 years of experience in clinical practice, teaching, and research in the field of integrated Chinese and Western medicine. She currently serves as the leader of the Department of Gastroenterology of Traditional Chinese Medicine at Yunnan Provincial Hospital of Chinese Medicine. Her daily responsibilities include diagnosing and treating patients with complex digestive diseases, mentoring master’s students, and overseeing research activities. She has established herself as a specialist who skillfully combines traditional Chinese medical therapies with modern Western treatments, offering holistic and effective patient care. Xia Chen’s leadership extends to supervising clinical trials and participating in national Phase II, III, and IV drug research studies. Her practical skills are complemented by her academic contributions, which include teaching future healthcare professionals and guiding research initiatives. Furthermore, she actively contributes to healthcare policy improvements through her roles in professional associations such as the Hepatobiliary Disease Branch of the Chinese Medical Association. Her professional experience highlights her comprehensive expertise across clinical, academic, and scientific domains, making her a pivotal figure in advancing the integration of traditional Chinese medicine with contemporary medical science.

Research Interests

Xia Chen’s research interests focus on the integration of traditional Chinese medicine and Western medicine approaches to digestive diseases. A significant part of her work explores the therapeutic effects of natural medicines on intestinal dynamics. Her research aims to scientifically validate the efficacy of traditional remedies and their mechanisms of action, thereby bridging the gap between ancient practices and modern clinical science. Additionally, Xia Chen is deeply interested in clinical trials related to new drug developments, having participated in numerous national Phase II, III, and IV studies. Her research spans studying gastrointestinal motility disorders, chronic digestive conditions, and hepatobiliary diseases. She is particularly motivated by the desire to develop more effective, less invasive, and side-effect-minimized treatments through integrative approaches. Another important research area for Xia Chen is understanding how traditional Chinese formulations can complement or enhance the effects of Western pharmacological interventions. Her research is highly practical, patient-centered, and innovative, targeting improvements in clinical outcomes. With a growing emphasis on evidence-based medicine, her work contributes significantly to validating and modernizing traditional Chinese medicinal practices while maintaining their historical integrity and therapeutic richness.

Research Skills

Xia Chen possesses a broad range of research skills that have been instrumental in her professional success. She demonstrates expertise in designing and conducting clinical trials, especially those combining traditional Chinese medicinal approaches with Western methodologies. Her skill set includes protocol development, patient recruitment and management, data analysis, and reporting in accordance with national and international standards. She is proficient in evaluating the pharmacological effects of natural medicines and their applications in digestive health. Xia Chen’s publication record highlights her ability to carry out longitudinal studies and synthesize findings for publication in peer-reviewed journals. Her role as a master’s supervisor also reflects her ability to guide young researchers in research design, methodology, and thesis writing. Furthermore, her participation in over ten national drug studies indicates advanced skills in regulatory compliance, clinical pharmacology, and interdisciplinary collaboration. Xia Chen’s integrated approach to traditional and modern research paradigms exemplifies her unique strengths. Her research methodology is thorough, combining qualitative insights from traditional Chinese medicine with the quantitative rigor required in modern clinical research. These combined skills make her a formidable researcher capable of making impactful contributions to the field.

Awards and Honors

Throughout her distinguished career, Xia Chen has received notable awards and honors recognizing her professional and academic contributions. She has been named an Outstanding Young Practitioner of Chinese Medicine in Yunnan Province, an accolade that underscores her clinical excellence, research innovation, and contributions to the advancement of traditional Chinese medicine. Her appointment as the leader of the Department of Gastroenterology of Traditional Chinese Medicine at the Yunnan Provincial Hospital of Chinese Medicine is itself a recognition of her expertise and leadership capabilities. Furthermore, her active membership in the Hepatobiliary Disease Branch of the Chinese Medical Association reflects national recognition of her skills and knowledge. These honors highlight her respected position within the Chinese medical community. They also affirm her commitment to bridging traditional Chinese medicine with modern clinical practices. While specific awards for research publications or international recognition have not been detailed, her extensive leadership in research projects and contribution to multiple monographs reinforce her academic and professional stature. Xia Chen’s awards and honors validate her significant and ongoing impact in the field of integrated medicine and gastroenterology.

Conclusion

Xia Chen is a highly accomplished clinician, educator, and researcher whose career embodies excellence in integrating traditional Chinese and Western medical practices. Her dedication to advancing digestive health through innovative, interdisciplinary methods sets her apart as a leader in her field. With over two decades of professional experience, leadership in major research projects, and numerous scholarly contributions, she has significantly impacted both clinical practice and academic research. Her recognition as an Outstanding Young Practitioner of Chinese Medicine and leadership roles within national medical organizations reflect her esteemed reputation. While opportunities exist for expanding her international research presence, Xia Chen’s current achievements already demonstrate her remarkable expertise, commitment, and influence. She serves as a bridge between ancient medical wisdom and contemporary science, promoting holistic and evidence-based healthcare solutions. As she continues to build on her impressive body of work, Xia Chen is poised to make even greater contributions to global medical science, ensuring that traditional Chinese medicine remains relevant, respected, and scientifically validated in the modern era.

Publications Top Notes

  • Title: Quercetin Inhibits Cardiomyocyte Apoptosis via Sirt3/SOD2/Mitochondrial Reactive Oxygen Species During Myocardial Ischemia–Reperfusion Injury

  • Authors: Xiong Da, Wang Xin, Wang Haiyu, Zhao Zicong, Ren Wenjun

  • Year: 2024

  • Citations: 6

Fei Liu | Medicine and Dentistry | Young Scientist Award

Published on by Shen Awards

Dr. Fei Liu | Medicine and Dentistry | Young Scientist Award

FeiDr. Fei Liu is a dedicated and emerging researcher affiliated with The Affiliated Hospital of Traditional Chinese Medicine, Southwest Medical University, China. His academic background is rooted in integrated traditional Chinese and Western medicine, with a research specialization in orthopedics. Dr. Liu has distinguished himself through his contributions to multiple research projects investigating the mechanisms of traditional Chinese medicine compounds and their therapeutic impact on orthopedic conditions. He is particularly focused on the pharmacological action of herbal formulas such as Duhuo Jisheng Tang, and their influence on pathways related to inflammation, apoptosis, and cellular metabolism. His scientific rigor is evident in his publication record, which includes six SCI-indexed journal articles (two as first author), and his involvement in several funded research grants at the provincial and municipal levels. Additionally, Dr. Liu holds a utility patent for an orthopedic surgical instrument, showcasing his commitment to clinical innovation. With a reputation for resilience, strong clinical foundations, and growing independent research capabilities, Dr. Liu is poised to make significant contributions to integrative medicine. Though early in his career, he has already demonstrated a promising trajectory, making him a strong candidate for emerging researcher recognition and a future contender for high-level scientific awards.

Professional Profile

Education

Dr. Fei Liu has pursued a comprehensive academic path in integrative medicine. He earned his undergraduate degree in Clinical Medicine of Integrated Traditional Chinese and Western Medicine from Hebei University of Chinese Medicine. This program laid a strong foundation in both conventional medical sciences and traditional Chinese therapeutic practices. Building upon this dual-focus education, he continued his studies at Southwest Medical University, where he undertook postgraduate training specializing in orthopedics within the same integrated clinical medicine discipline. His graduate research has centered on understanding the therapeutic mechanisms and efficacy of traditional herbal formulas used in orthopedic disorders. Dr. Liu’s educational experiences have provided him with a rare and valuable interdisciplinary skill set, enabling him to explore the complex biological interactions between traditional herbal compounds and modern biomedical systems. As a graduate student, he not only excelled academically—earning multiple prestigious scholarships—but also contributed actively to the academic community, serving as a student party committee member and engaging in various academic assistance roles. These educational milestones have shaped Dr. Liu into a well-rounded medical scientist with the tools to bridge traditional and modern medical practices effectively.

Professional Experience

Dr. Fei Liu’s professional journey has been primarily rooted in research and clinical training within the setting of Southwest Medical University and its affiliated hospital. During his postgraduate studies, he played significant roles in multiple ongoing research projects funded by the Sichuan Provincial Science and Technology Department, the Luzhou municipal government, and other institutional partnerships. He served as a second or third principal researcher on several studies investigating the pharmacological mechanisms of Duhuo Jisheng Tang and other herbal compounds in treating musculoskeletal disorders, particularly intervertebral disc degeneration. His work has involved both clinical observation and experimental design, contributing to tasks such as laboratory assay development, animal model experimentation, molecular analysis, and data interpretation. In parallel with his research activities, Dr. Liu has been involved in routine clinical work, managing patient admissions and performing basic surgical procedures such as internal fixation removals. His practical experience complements his scientific training, allowing him to integrate clinical insight with research innovation. Furthermore, he has actively participated in academic and administrative duties, serving within the student branch of the Party Committee and taking part in academic assistance programs. This balance of clinical proficiency and research engagement highlights his growing capacity as a clinician-scientist.

Research Interests

Dr. Fei Liu’s research interests lie at the intersection of traditional Chinese medicine (TCM) and modern biomedical science, with a particular focus on orthopedic applications. He is especially passionate about elucidating the pharmacological and molecular mechanisms underlying traditional herbal formulas, such as Duhuo Jisheng Tang, in the treatment of degenerative musculoskeletal conditions like intervertebral disc degeneration and osteoporosis. His projects have explored how these formulas influence biological pathways such as the JNK/P38MAPK signaling cascade, apoptosis (pyroptosis), glycolysis, and extracellular matrix degradation. Beyond musculoskeletal disorders, Dr. Liu has also contributed to interdisciplinary studies examining the immunological connections between COVID-19 and osteoporosis, and how m6A methylation affects prognosis and immunotherapy response in hepatocellular carcinoma. His holistic research approach integrates bioinformatics, in vivo and in vitro experimentation, and clinical data analysis. Dr. Liu is particularly interested in the potential of TCM to provide alternative therapeutic pathways with fewer side effects than synthetic drugs, especially when guided by modern research tools. His work contributes to the evolving field of integrative medicine, aiming to validate traditional knowledge using contemporary scientific methods and to promote evidence-based use of herbal treatments in modern clinical settings.

Research Skills

Dr. Fei Liu has developed a robust portfolio of research skills, well-suited to translational and interdisciplinary biomedical research. He possesses hands-on expertise in molecular biology techniques such as Western blotting, PCR, immunohistochemistry, and ELISA, which he has applied to study cellular signaling pathways in degenerative disc disease and related orthopedic conditions. In his various research projects, he has been actively involved in experimental design, animal modeling, data collection, statistical analysis, and manuscript preparation. Dr. Liu is also skilled in the use of bioinformatics tools for gene expression profiling and pathway analysis, which has allowed him to examine complex interactions between inflammation, immune response, and cellular metabolism. Additionally, he is familiar with biomechanical modeling, demonstrated by his collaborative work on lumbar spine simulations. His competence extends to academic writing, with several SCI-indexed journal publications, and to intellectual property development, as evidenced by his patent for a novel orthopedic surgical device. These combined skills reflect a balance of laboratory precision, analytical capability, and creative innovation. His ability to manage multiple research tasks while contributing meaningfully to both clinical and academic settings illustrates a strong foundation for continued scientific growth.

Awards and Honors

Throughout his academic career, Dr. Fei Liu has received several honors and recognitions that underscore his excellence in research and academic performance. He was awarded the National Second-Class Academic Scholarship for the 2020–2021 academic year and subsequently received the National First-Class Academic Scholarship for 2021–2022, highlighting his consistent academic distinction. In addition, he was honored with the “Kangzhe” Scholarship, a prestigious recognition of research potential in medical innovation. Dr. Liu has also been named an Outstanding Graduate Student of the 2020 cohort at his university, a distinction awarded to students demonstrating exceptional contributions in both research and leadership. His early commitment to scholarly excellence is further reflected in his participation as a student party committee member and his contributions to academic assistance initiatives. These accolades are not only a reflection of his academic abilities but also of his leadership qualities, dedication, and strong work ethic. They serve as indicators of his upward trajectory as a medical researcher and clinician. These honors reinforce his reputation as a promising young scholar, capable of making meaningful contributions to the field of integrative and orthopedic medicine.

Conclusion

In conclusion, Dr. Fei Liu exemplifies the qualities of a promising clinician-scientist whose work bridges traditional Chinese medicine and contemporary biomedical science. With a solid academic foundation, diverse professional experience, and a focused research agenda, he has contributed meaningfully to both experimental and translational studies. His involvement in several major research projects and his growing publication record demonstrate his potential for independent research leadership. Dr. Liu’s work not only advances understanding in the field of orthopedics but also enhances the scientific credibility of traditional medicine through rigorous investigation. He has already earned a patent, multiple scholarships, and recognitions that reflect his dedication and innovation. Although still in the early stages of his research career, he has established a strong foundation for future contributions at the national and international levels. With continued mentorship, expanded collaboration, and increased leadership in principal investigator roles, Dr. Liu is well-positioned to evolve into a leading figure in integrative medical research. His achievements to date make him a strong candidate for recognition in emerging researcher categories and a future contender for more senior scientific awards as his academic and professional journey progresses.

Publications Top Notes

Kandi Zhang | Medicine and Dentistry | Best Researcher Award

Published on by Shen Awards

Dr. Kandi Zhang | Medicine and Dentistry | Best Researcher Award

Doctor from Department of Cardiology, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, China

Dr. Kandi Zhang is an emerging medical researcher and clinician specializing in internal medicine with a primary focus on cardiology. Born in September 1993, she is currently affiliated with the Department of Cardiology at Shanghai Ninth People’s Hospital, which is part of Shanghai Jiao Tong University School of Medicine, one of China’s most prestigious institutions. Her clinical and research work reflects a strong dedication to advancing diagnostic and therapeutic methods for cardiovascular diseases, particularly through innovative applications of imaging technologies, antiplatelet therapies, and proteomic biomarker analysis. She has authored several peer-reviewed publications that explore the clinical and molecular aspects of acute coronary syndrome and myocardial infarction. Dr. Zhang’s combination of academic rigor and hands-on clinical expertise has allowed her to contribute meaningful insights to the field. Her collaborations with interdisciplinary teams and consistent publication in high-quality journals suggest a trajectory toward leadership in cardiovascular medicine. With a commitment to both patient-centered care and scientific discovery, she bridges the gap between medical innovation and clinical practice, positioning herself as a key contributor to the future of life sciences research in cardiology.

Professional Profile

Education

Dr. Kandi Zhang holds a Doctorate in Internal Medicine, earned through advanced medical education and research training at the Shanghai Jiao Tong University School of Medicine. This institution is internationally recognized for its rigorous curriculum, cutting-edge medical technology, and high-impact research environment. Her academic background provided her with comprehensive knowledge in physiology, pathology, pharmacology, and advanced clinical methodologies, with a particular concentration in cardiovascular medicine. During her doctoral studies, Dr. Zhang received mentorship from leading cardiologists and participated in clinical rotations and research initiatives at Shanghai Ninth People’s Hospital. The combination of theoretical education and practical exposure enabled her to specialize in both diagnosis and treatment of complex cardiac conditions. Her doctoral research likely involved extensive literature reviews, experimental design, clinical data analysis, and application of medical imaging and laboratory techniques. This educational foundation established her competence in evidence-based medicine, advanced diagnostics, and translational research. Through this training, she cultivated the analytical, technical, and clinical judgment skills required to contribute effectively to medical science. Her continuous engagement in academic publishing indicates that she has maintained a strong scholarly presence beyond her formal education, enriching her academic qualifications with real-world impact.

Professional Experience

Dr. Kandi Zhang’s professional experience is rooted in her role at the Department of Cardiology, Shanghai Ninth People’s Hospital, a highly respected clinical and research institution in China. As a practicing cardiologist and medical researcher, she is actively involved in both patient care and scientific inquiry. Her responsibilities include diagnosing and managing cardiovascular disorders, performing and interpreting diagnostic imaging, and participating in interdisciplinary case consultations. In parallel, she conducts clinical research with a focus on cardiovascular interventions, such as myocardial infarction management without reperfusion, left atrial appendage closure procedures, and the use of proteomic platforms to analyze biomarkers in acute coronary syndrome. Her position allows her to translate bedside observations into research hypotheses, bridging clinical care with data-driven innovation. Additionally, Dr. Zhang collaborates with colleagues across departments and institutions, contributing to multi-author research papers and bringing new insights to existing cardiology practices. Her dual engagement in research and clinical services provides a unique advantage, allowing her to contribute to real-time advancements in treatment protocols. This experience has also enhanced her leadership capabilities in conducting clinical trials, publishing scientific findings, and shaping evidence-based medical practices, making her a valuable contributor to both national and international cardiology communities.

Research Interest

Dr. Kandi Zhang’s research interests lie at the intersection of clinical cardiology, cardiovascular imaging, and molecular biomarker discovery. Her scholarly pursuits focus on improving diagnostic and therapeutic strategies for acute and chronic cardiac conditions, including myocardial infarction, atrial fibrillation, and acute coronary syndrome. She is particularly interested in the pre-treatment efficacy of antiplatelet medications in non-reperfused myocardial infarction cases, a subject with significant implications for emergency cardiac care. Another key area of her research involves comparative studies of imaging modalities for left atrial appendage closure—an essential technique for stroke prevention in atrial fibrillation patients. Her recent work has expanded into proteomics, exploring biomarker signatures in young patients with acute coronary syndrome, which opens possibilities for personalized medicine and early detection strategies. Dr. Zhang is committed to translational research that can swiftly impact clinical decision-making. By integrating data from various sources—including imaging, clinical trials, and molecular assays—her work advances the precision and effectiveness of cardiac interventions. She aspires to contribute to the development of non-invasive, cost-effective, and scalable diagnostics for cardiovascular diseases. Her research interests reflect a broader vision of integrating technology, biology, and clinical medicine to address pressing challenges in heart health globally.

Research Skills

Dr. Kandi Zhang possesses a robust set of research skills that complement her clinical expertise. Her methodological proficiency spans clinical trial design, statistical analysis, medical imaging evaluation, and biomarker identification using proteomics. She is adept at using various imaging techniques to support therapeutic interventions, as evidenced by her publication on evaluating orifice diameters for atrial appendage closure. Her familiarity with experimental protocols, animal models, and in vitro assays—such as her work on myocardial infarction in mice—demonstrates her versatility in both basic and applied research. She also shows skill in bioinformatics and data interpretation, especially in translating proteomic findings into clinically relevant insights. Furthermore, she has strong experience in scholarly writing, data visualization, and peer-reviewed publishing, which are essential for knowledge dissemination and academic contribution. Her ability to work collaboratively on multi-author projects highlights her communication and teamwork skills, crucial for multidisciplinary research environments. Dr. Zhang is also proficient in integrating patient data with clinical outcomes, allowing for a nuanced understanding of treatment efficacy. These research skills enable her to contribute to innovative, evidence-based practices in cardiology, and position her as a strong candidate for collaborative projects across the life sciences and medical research domains.

Awards and Honors

While specific named awards are not explicitly listed in the available profile, Dr. Kandi Zhang’s consistent publication in high-impact, peer-reviewed journals and affiliation with a top medical university suggest academic excellence and institutional recognition. Being a first or lead author in multiple scientific papers published in journals such as Cardiology Journal, Clinical Cardiology, and Frontiers in Cardiovascular Medicine indicates that her work is well-regarded within the cardiology and life sciences communities. Such scholarly visibility often accompanies internal honors such as best researcher accolades, conference recognitions, or research funding awards within the academic medical network. Her role at Shanghai Ninth People’s Hospital—a center for high-level research and patient care—also implies that she has undergone competitive selection processes and met stringent performance standards. Moreover, her early-career contributions, particularly in bridging clinical and molecular research, may position her for future international awards in cardiovascular research and life sciences innovation. If she continues on this trajectory, it is likely that formal recognitions and honors will follow as her influence in the field expands.

Conclusion

Dr. Kandi Zhang exemplifies the qualities of an innovative and impactful researcher in the field of life sciences, particularly in cardiovascular medicine. Through a combination of clinical practice, rigorous academic training, and a solid research portfolio, she has established herself as a credible and forward-thinking contributor to cardiology. Her studies on antiplatelet drug efficacy, imaging modality optimization, and proteomics-based biomarker identification highlight her commitment to solving real-world health challenges through science. While her profile would benefit from broader international exposure and interdisciplinary collaboration, her current achievements mark her as a rising figure in translational cardiovascular research. With continued effort and strategic partnerships, she is well-positioned to lead impactful projects that could redefine patient care standards in cardiology. As she advances in her career, Dr. Zhang has the potential to influence both academic and clinical landscapes, making her a strong candidate for recognition through life sciences innovation awards and future leadership roles in global medical research.

Publications Top Notes

  • Does Spontaneous Echo Contrast in the Left Atrial Appendage Increase Thromboembolism Risk After Left Atrial Appendage Closure? A Retrospective Study on Its Impact on Device‐Related Thrombosis and Arterial Thromboembolic Events

    • Authors: Kandi Zhang, Hanwen Yu, Yihua Lu, Peng Zhang, Dongsheng Liu, Jianpeng Huang, Jing Zhou, Yiqian Yuan, Zongqi Zhang, Qingyong Zhang et al.

    • Year: 2025

  • Clinical Characteristics and Biomarkers Feature Analysis Using a Proteomics Platform in Young Patients with Acute Coronary Syndrome

    • Authors: Zhang K, Wang F, Yu Q, Song Y, Gu J, He Q, Zhang J

    • Year: 2024

  • Angiopoietin-like Protein 2 Inhibits Thrombus Formation

    • Authors: Zhang T, Zhang M, Guo L, Liu D, Zhang K, Bi C, Zhang P, Wang J, Fan Y, He Q et al.

    • Year: 2024

  • Identification of Shared Molecular Mechanisms and Diagnostic Biomarkers Between Heart Failure and Idiopathic Pulmonary Fibrosis

    • Authors: Zhang P, Geng L, Zhang K, Liu D, Wei M, Jiang Z, Lu Y, Zhang T, Chen J, Zhang J

    • Year: 2024

  • AGK Potentiates Arterial Thrombosis by Affecting Talin-1 and αIIbβ3-Mediated Bidirectional Signaling Pathway

    • Authors: Zhang P, Jiang H, Yang M, Bi C, Zhang K, Liu D, Wei M, Jiang Z, Keyu Lv, Fang C et al.

    • Year: 2023

  • Role of GPR56 in Platelet Activation and Arterial Thrombosis

    • Authors: Liu D, Zhang P, Zhang K, Bi C, Li L, Xu Y, Zhang T, Zhang J

    • Year: 2022

  • Comparison of Multiple Imaging Modalities for Measuring Orifice Diameter and Selecting Occluder Size in Patients Undergoing Left Atrial Appendage Closure

    • Authors: Kandi Zhang, Jing Zhou, Tiantian Zhang, Zongqi Zhang, Shanliang Jin, Qing He, Junfeng Zhang

    • Year: 2022

  • Pretreatment with Antiplatelet Drugs Improves the Cardiac Function After Myocardial Infarction Without Reperfusion in a Mouse Model

    • Authors: Zhang K, Yang W, Zhang M, Sun Y, Zhang T, Liu J, Zhang J

    • Year: 2019

  • Paired Immunoglobulin-like Receptor B Regulates Platelet Activation

    • Authors: Fan X, Shi P, Dai J, Lu Y, Chen X, Liu X, Zhang K, Wu X, Sun Y, Wang K et al.

    • Year: 2014

Murtii Teressa Obolu | Medicine and Dentistry | Best Researcher Award

Published on by Shen Awards

Dr. Murtii Teressa Obolu | Medicine and Dentistry | Best Researcher Award

Corresponding Author from Hawassa university, Ethiopia

Dr. Murti Teressa Obolu is a dedicated surgical resident with a strong background in clinical practice, medical education, leadership, and research. His expertise spans multiple surgical disciplines, including General Surgery, Cardiothoracic Surgery, Pediatric Surgery, and Neurosurgery. He has actively contributed to medical education and institutional development, serving in key leadership roles at Mizan Tepi University. His research interests are reflected in his numerous publications, including original research articles and case reports in international journals. As an active member of various professional organizations, including the Ethiopian Surgical Society and COSECSA, he remains committed to advancing surgical research and education in Ethiopia and beyond. His outstanding academic performance and leadership skills have earned him multiple awards, highlighting his contributions to surgical training and medical research. With a strong commitment to academic excellence, research, and clinical expertise, Dr. Obolu is poised to make significant contributions to the medical field both nationally and internationally.

Professional Profile

Education

Dr. Obolu completed his Doctor of Medicine (MD) degree at Jimma University Institute of Health, where he graduated with distinction. During his medical training, he excelled in leadership and academic coordination. He later pursued a surgical residency at Hawassa University, College of Medicine and Health Sciences, where he was recognized as the Outstanding Year One Resident in collaboration with the American College of Surgeons. His intensive residency training has provided him with hands-on experience in various surgical disciplines, including Pediatric Surgery, Neurosurgery, Urologic Surgery, Cardiothoracic Surgery, and Vascular Surgery. His strong academic background, combined with rigorous clinical exposure, has prepared him for a career dedicated to advancing surgical care and research. His medical education also includes an internship at Jimma University Medical Center, where he gained extensive practical experience in patient management and surgical procedures. His academic journey reflects a strong foundation in both medical education and surgical expertise, reinforcing his potential as a leading researcher and clinician.

Professional Experience

Dr. Obolu has extensive professional experience in both academic and clinical settings. He served as a General Practitioner and Lecturer at Mizan Tepi University, where he played a vital role in medical education and institutional leadership. His responsibilities included serving as the Head of the Department of Surgery, Undergraduate Academic Coordinator, and Vice Dean of the School of Medicine. His contributions were instrumental in the establishment of the School of Medicine and the development of medical education programs. In his surgical residency at Hawassa University, he has gained hands-on experience performing complex surgical procedures across multiple specialties. His role as a Senior Surgical Resident and Chief Resident has further strengthened his leadership and clinical expertise. His professional journey highlights a combination of surgical proficiency, academic leadership, and a strong commitment to medical education. His extensive experience in teaching and mentoring medical students and junior doctors underscores his dedication to shaping the future of medical practice in Ethiopia and beyond.

Research Interest

Dr. Obolu’s research interests are centered on advancing surgical science and improving patient outcomes in specialized fields such as Cardiothoracic Surgery, Pediatric Neurosurgery, and General Surgery. He is particularly focused on exploring innovative surgical techniques, enhancing post-operative patient care, and addressing healthcare challenges in resource-limited settings. His commitment to research extends to investigating rare surgical cases, improving surgical education methodologies, and contributing to evidence-based surgical practices. He is also passionate about developing collaborative research initiatives that bridge gaps between clinical practice and academic research. Through his involvement in various research projects, he aims to contribute to the advancement of surgical knowledge and innovation, particularly in Ethiopia and across Africa. His long-term vision includes integrating advanced surgical technologies and methodologies into local healthcare systems to enhance the quality of surgical care.

Research Skills

Dr. Obolu possesses strong research skills, including expertise in clinical research design, data analysis, academic writing, and peer-reviewed publication processes. He has successfully authored and co-authored multiple original research articles and case reports in international journals. His ability to conduct independent and collaborative research is reflected in his role as a corresponding author for several ongoing studies. He is proficient in utilizing research databases, statistical software, and evidence-based methodologies to conduct high-quality medical research. His experience in research mentorship and academic leadership has enabled him to guide medical students and junior researchers in developing their research capabilities. His research expertise also extends to systematic literature reviews, clinical trials, and epidemiological studies, reinforcing his ability to contribute significantly to the field of surgical research.

Awards and Honors

Dr. Obolu has received multiple awards and honors in recognition of his academic excellence, leadership, and contributions to surgical training. He was awarded the Outstanding Year One Resident (2022) by Hawassa University in collaboration with the American College of Surgeons. His leadership in medical education earned him Leadership Excellence Awards from Mizan Tepi University. He has also been recognized for his contributions to the establishment and growth of the School of Medicine at Mizan Tepi University. His achievements highlight his dedication to academic excellence, clinical leadership, and research contributions. Additionally, he holds certifications for leadership and academic excellence from various institutions, further reinforcing his status as a distinguished medical professional. His active membership in prestigious surgical organizations, including COSECSA, Ethiopian Surgical Society, and Ethiopian Medical Association, demonstrates his commitment to professional development and surgical innovation.

Conclusion

Dr. Murti Teressa Obolu is a highly skilled and dedicated surgical resident with a strong foundation in research, medical education, and clinical practice. His numerous contributions to the medical field, including leadership roles, research publications, and surgical training, reflect his commitment to advancing healthcare in Ethiopia and beyond. His recognition as an outstanding resident and academic leader further highlights his potential as a future leader in surgery and medical research. While he has already made significant strides in research and clinical practice, expanding his research collaborations, securing independent research funding, and increasing international conference participation will further solidify his reputation as a top researcher. His passion for surgery, dedication to patient care, and commitment to academic excellence position him as a promising candidate for future research and leadership opportunities in the medical field.

Publications Top Notes

  1. Title: Multiple Giant Cerebral Hydatid Cysts in Pediatrics
    Authors: Dagnachew Yohannes Gechera, Murtii Teressa Obolu, Abdulaziz Abdellah Hussein, Yared Assefa Beyene, Tadesse Getachew Mulisa, Kibrom Legesse Abrha
    Year: 2025

  2. Title: Gangrenous prolapsed Sigmoidorectal intussusception
    Authors: Murtii Teressa Obolu
    Year: 2025

  3. Title: Ileo-Ileal Knotting in 60 years male patient
    Authors: Murtii Teressa Obolu
    Year: 2025

  4. Title: Rare Initial Neurological Presentation of Cervical Spine Metastases in Hepatocellular Carcinoma; A case report
    Authors: Murtii Teressa Obolu
    Year: 2024

  5. Title: Ileo-Ileal Knotting: A Case Report of a 60-Year-Old Male Patient in Hawassa University Comprehensive Specialized Hospital, Hawassa, Sidama, Ethiopia
    Authors: Tewodros Tadesse, Abdullahi Mohamed Muhumed, Murtii Teressa Obolu, Gediyon Getachew Gebo
    Year: 2024

  6. Title: Appendico-Ileal Knotting: A Case Report of 17-Year-Old Female Patient in Hawassa University Comprehensive Specialized Hospital, Hawassa, Sidama, Ethiopia
    Authors: Murtii Teressa, Tewodros Tadesse, Tadesse Getachow, Ermias Tadesse
    Year: 2024

  7. Title: Adult Hirschsprung’s Disease
    Authors: Murtii Teressa Obolu
    Year: 2024

  8. Title: SARS-CoV-2 Infections, Clinical Characteristics, and Related Risk Factors: The First 8 Months Surveillance Study Conducted in Southwest Ethiopia
    Authors: Dassalegn Muleta, Asnake Simieneh, Tadesse Duguma, Eyob Tekalign, Teshale Worku, Gizachew Ayele, Yayeh Melaku, Abdulrezak Nuri, Murtii Teressa, Adinew Belay, et al.
    Year: 2023

  9. Title: Detection of Mycobacterium tuberculosis using Gene Xpert-MTB/RIF assay among tuberculosis suspected patients at Mizan-Tepi University Teaching Hospital, Southwest Ethiopia: An institution-based cross-sectional study
    Authors: Mengistu Abayneh Sebsibe, Murtii Teressa, Sebsibe Tadesse
    Year: 2022

  10. Title: Acute respiratory infections (ARIs) and factors associated with their poor clinical outcome among children under-five years attending pediatric wards of public hospital in Southwest district of Ethiopia: A prospective observational cohort study
    Authors: Mengistu Abayneh Sebsibe, Dassalegn Muleta, Asnake Simieneh, Tadesse Duguma, Molla Asnake, Murtii Teressa, Biruk Endalkachew, Milkiyas Toru
    Year: 2022

  11. Title: Post Traumatic Pneumomediastinum in Pediatrics
    Authors: Murtii Teressa Obolu

 

Sheng Guan | Medicine and Dentistry | Best Researcher Award

Published on by Shen Awards

Prof. Dr. Sheng Guan | Medicine and Dentistry | Best Researcher Award

Director Physician from THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY, China

Dr. Sheng Guan is a distinguished medical professional specializing in imaging medicine and neurological intervention. He serves as the Director of the Department of Imaging Medicine and Interventional Medicine at the First Affiliated Hospital of Zhengzhou University and leads the Department of Neurological Intervention. Additionally, he is the Director of the Neurological Intervention Engineering Research Centre of Henan Province. His expertise primarily focuses on cerebrovascular diseases, with a significant impact on advancing medical research and treatment strategies. Over the years, he has contributed extensively to the field through his research, leadership, and clinical innovations. With more than 200 published papers, including 84 as the first or corresponding author and 55 SCI-indexed papers, his academic contributions are well-recognized internationally. His work is frequently published in renowned journals such as JVIR, CVIR, and ER. Dr. Sheng Guan has also received two provincial scientific and technological progress awards, further solidifying his reputation as a leading researcher. His dedication to improving medical interventions and expanding knowledge in cerebrovascular diseases highlights his commitment to the field. With an extensive research background, strong leadership, and a proven track record of excellence, Dr. Sheng Guan continues to be a key figure in medical research and innovation.

Professional Profile

Education

Dr. Sheng Guan has a strong academic foundation that has supported his extensive career in imaging medicine and neurological intervention. He completed his medical education at a prestigious institution, where he specialized in radiology and interventional medicine. His postgraduate studies focused on cerebrovascular diseases, equipping him with the expertise required for advanced medical research and patient care. Over the years, he has pursued additional professional training, including specialized courses and workshops on imaging techniques, neurological interventions, and vascular research methodologies. His academic journey includes collaborations with top researchers and institutions, further enhancing his knowledge and skills in the field. Dr. Sheng Guan has also engaged in continuous learning through international medical conferences, professional exchanges, and advanced certifications in interventional radiology. His education has provided a strong theoretical and practical foundation, enabling him to contribute significantly to both clinical practice and medical research. As an academic leader, he has also mentored numerous students and young researchers, fostering a new generation of medical professionals in the field of imaging medicine and cerebrovascular research. His commitment to lifelong learning and education continues to drive his contributions to scientific advancements and medical innovation.

Professional Experience

Dr. Sheng Guan has an extensive professional background, marked by leadership roles, clinical excellence, and research achievements. He is currently the Director of the Department of Imaging Medicine and Interventional Medicine at the First Affiliated Hospital of Zhengzhou University, where he leads a team of medical professionals in advancing imaging and neurological intervention techniques. Additionally, he serves as the Director of the Department of Neurological Intervention and heads the Neurological Intervention Engineering Research Centre of Henan Province. His expertise in cerebrovascular diseases has enabled him to develop innovative treatment approaches that have improved patient outcomes. Throughout his career, he has been actively involved in both research and clinical practice, integrating cutting-edge imaging and intervention technologies into medical treatment. His professional experience also includes collaboration with international experts, participation in global medical conferences, and contributions to high-impact scientific journals. Dr. Sheng Guan’s leadership has been instrumental in establishing research programs, securing funding for medical studies, and mentoring young researchers. His commitment to both clinical excellence and research innovation has earned him recognition within the medical community, making him a key figure in the advancement of interventional medicine and cerebrovascular research.

Research Interest

Dr. Sheng Guan’s primary research interest lies in cerebrovascular diseases, particularly in the development of advanced imaging techniques and interventional treatments for neurological disorders. His work focuses on improving the diagnosis, treatment, and prevention of conditions such as stroke, aneurysms, and vascular malformations. He is particularly interested in exploring minimally invasive intervention methods that can enhance patient recovery and reduce medical complications. His research extends to the application of artificial intelligence and machine learning in imaging medicine, aiming to improve diagnostic accuracy and treatment planning. Additionally, he is involved in studies on neurovascular stents, embolization techniques, and innovative therapeutic approaches to cerebrovascular diseases. Dr. Sheng Guan actively collaborates with national and international research teams to develop new technologies and methodologies in imaging medicine. His research also aims to bridge the gap between clinical practice and scientific advancements, ensuring that new medical discoveries are effectively translated into patient care. Through his contributions, he has significantly influenced the field of neurological intervention and continues to drive innovation in cerebrovascular research. His dedication to expanding knowledge and improving medical interventions underscores his commitment to advancing healthcare and scientific discovery.

Research Skills

Dr. Sheng Guan possesses a comprehensive set of research skills that have enabled him to make significant contributions to imaging medicine and neurological intervention. He is proficient in advanced imaging techniques, including magnetic resonance imaging (MRI), computed tomography (CT), and digital subtraction angiography (DSA), which are essential for diagnosing and treating cerebrovascular diseases. His expertise in interventional radiology allows him to develop and apply minimally invasive procedures for neurological conditions. Dr. Sheng Guan is also skilled in clinical trials and experimental research, having conducted numerous studies to evaluate the effectiveness of new treatments and technologies. His ability to analyze large datasets and interpret complex medical imaging results has contributed to his success in developing innovative diagnostic and therapeutic approaches. Additionally, he is experienced in academic writing and peer-reviewed publishing, having authored over 200 research papers in high-impact journals. His skills in grant writing and securing research funding have supported his extensive scientific investigations. Moreover, his leadership in multidisciplinary research teams highlights his ability to coordinate and manage large-scale medical studies. Through his technical expertise, analytical skills, and collaborative approach, Dr. Sheng Guan continues to advance the field of imaging medicine and cerebrovascular research.

Awards and Honors

Dr. Sheng Guan has received numerous awards and honors in recognition of his outstanding contributions to medical research and clinical practice. He has been awarded two provincial scientific and technological progress awards, which acknowledge his significant achievements in cerebrovascular research and neurological intervention. His work has been widely recognized by academic and medical institutions, and he has been invited as a speaker at various international medical conferences. Additionally, his contributions to the field have earned him positions on the editorial boards of prestigious journals such as JVIR, CVIR, and ER. His research excellence has also been acknowledged through multiple research grants and funding opportunities, supporting his ongoing investigations into cerebrovascular diseases. Dr. Sheng Guan’s dedication to medical innovation and patient care has earned him the respect of his peers, as well as accolades from both national and international medical organizations. His leadership and commitment to scientific discovery continue to make a profound impact on the field of imaging medicine. With a strong record of achievements and recognition, Dr. Sheng Guan remains a highly influential figure in neurological intervention and medical research.

Conclusion

Dr. Sheng Guan is a highly accomplished researcher and medical professional specializing in imaging medicine and neurological intervention. His extensive academic background, leadership roles, and research contributions have positioned him as a leading expert in cerebrovascular diseases. With over 200 published papers, significant awards, and a strong presence in international scientific communities, his impact on medical research is undeniable. His dedication to advancing diagnostic and interventional techniques has improved treatment outcomes for numerous patients. Additionally, his ability to lead multidisciplinary teams, secure research funding, and mentor young professionals further enhances his contributions to the field. While he has already established himself as a distinguished figure in medical research, expanding his global collaborations and exploring interdisciplinary approaches could further strengthen his influence. Dr. Sheng Guan’s commitment to scientific excellence and innovation makes him a deserving candidate for the Best Researcher Award. His work continues to shape the future of imaging medicine and neurological intervention, setting new standards in patient care and medical research. Through his expertise, leadership, and unwavering dedication, he remains at the forefront of cerebrovascular research and medical advancements.

Publication Top Notes

  • Title: Safety and efficacy of staged coiling followed by flow diverter in the treatment of ruptured intracranial aneurysms
    Authors: Y. Li, Yuanzhi; F. Fan, Feng; Z. Chen, Zhen; Y. Fu, Yu; S. Guan, Sheng
    Year: 2025

  • Title: Safety and efficacy of intrasaccular flow disruptor in intracranial aneurysms
    Authors: Y. Li, Yuanzhi; F. Fan, Feng; S. Guan, Sheng
    Year: 2025

  • Title: Value of difference in diameters between Pipeline embolization device and parent artery in assessing aneurysm outcome
    Authors: Y. Ma, Yajing; H. Zhang, Hang; C. Liu, Chao; S. Guan, Sheng; X. Guo, Xinbin
    Year: 2025

  • Title: Reconstructive Endovascular Treatment of Compensative-Flow–Related Posterior Circulation Aneurysms With Anterior Circulation Artery Occlusion
    Authors: T. Quan, Tao; X. Zhang, Xin; J. Li, Jinyi; C. Duan, Chuanzhi; S. Guan, Sheng
    Year: 2025

  • Title: Neuroform Atlas stent-assisted coil embolization for middle cerebral artery bifurcation aneurysms: a multicenter retrospective study
    Authors: M. Fan, Mengyan; J. Li, Jing; C. Duan, Chuanzhi; J. Zhang, Jiamei; S. Guan, Sheng
    Year: 2025

  • Title: A review of new advances in neuro-intervention
    Authors: X. Fu, Xiaojie; W. Gong, Wentao; S. Guan, Sheng
    Year: 2025

  • Title: Efficacy and safety of intrasaccular flow disruptor in wide-necked intracranial aneurysms: a multicenter retrospective study
    Authors: X. Zhang, Xiaowen; J. Li, Jing; X. Li, Xifeng; X. Zhang, Xin; S. Guan, Sheng
    Year: 2025
    Citations: 1

  • Title: MR vessel wall imaging for predicting instability status of intracranial aneurysm
    Authors: X. Ma, Xinmei; Q. Fu, Qichang; S. Xie, Shanshan; J. Cheng, Jingliang; S. Guan, Sheng
    Year: 2025

  • Title: The oral microbiota: new insight into intracranial aneurysms
    Authors: W. Gong, Wentao; H. Yu, Hairong; W. You, Wei; Y. Li, Youxiang; S. Guan, Sheng
    Year: 2025

  • Title: Diagnosis of intracranial aneurysms by computed tomography angiography using deep learning-based detection and segmentation
    Authors: W. You, Wei; J. Feng, Junqiang; J. Lu, Jing; Y. Jiang, Yuhua; Y. Wang, Yan
    Year: 2024
    Citations: 4

 

 

Weitao Man | Medicine and Dentistry | Best Researcher Award

Published on by Shen Awards

Dr. Weitao Man | Medicine and Dentistry | Best Researcher Award

Neurosurgeon From Tsinghua University, China

Dr. Weitao Man is a distinguished attending physician in neurosurgery and an associate researcher at Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing, China. His expertise spans various areas of neurosurgery, particularly focusing on spinal cord injury, neurodegenerative diseases, and neurophysiology. With a solid academic background and clinical experience, Dr. Man has contributed extensively to the advancement of neuroscientific research and clinical treatments, particularly through his innovative work on biomaterials and regenerative medicine. His clinical approach integrates cutting-edge research findings with a compassionate patient care model, making him a prominent figure in his field.

Professional Profile

Education

Dr. Man’s educational journey began at Southern Medical University in Guangzhou, China, where he earned his Bachelor of Clinical Medicine in 2012. He further pursued his passion for neurosurgery, completing a Master’s in Neurosurgery from Capital Medical University in 2015. In 2021, he obtained his Ph.D. in Medicine from Tsinghua University under the mentorship of Professor Guihuai Wang. His rigorous academic training has laid the foundation for his exceptional contributions to the field of neurosurgery, focusing on spinal cord injury and neuroregenerative medicine.

Professional Experience

Dr. Man has a broad and distinguished career in both clinical practice and research. Currently, he serves as an attending neurosurgeon and associate researcher at Beijing Tsinghua Changgung Hospital, a role he has held since 2023. His earlier experiences include a post-doctoral fellowship at Massachusetts General Hospital, Harvard Medical School, and residency positions in renowned hospitals such as Sanbo Brain Hospital and Beijing Tsinghua Changgung Hospital. His career reflects a blend of hands-on clinical work and high-level scientific investigation, contributing to advancements in the field of neurosurgery.

Research Interests

Dr. Man’s primary research interests lie in the areas of spinal cord injury, neurodegenerative diseases, and the development of innovative biomaterials for neurosurgery. He is particularly focused on the molecular mechanisms of microglial polarization and its role in spinal cord regeneration. His work also includes the development of hydrogels and biomimetic exosomes as potential therapies for spinal cord injury. Dr. Man’s research bridges the gap between basic science and clinical application, aiming to improve the quality of life for patients suffering from neurological disorders.

Research Skills

Dr. Man is skilled in a wide array of advanced research techniques, including molecular biology, tissue engineering, and biocompatible material development. He has experience in utilizing animal models for neurodegenerative disease research and spinal cord injury repair. His expertise also extends to advanced imaging techniques, such as ultrafast power Doppler imaging, and the development of innovative biomaterials like conductive hydrogels for neural interfaces. These skills, combined with his strong analytical background, enable him to contribute significantly to both experimental research and clinical applications.

Awards and Honors

Throughout his career, Dr. Man has received numerous accolades for his groundbreaking work in neurosurgery and neuroregenerative medicine. His work on neurodegenerative diseases, particularly Parkinson’s disease and spinal cord injury, has garnered attention in prestigious medical journals and conferences. Dr. Man’s ability to combine clinical expertise with pioneering research has earned him recognition both in China and internationally, including funding from the Natural Science Foundation of China and the Beijing Natural Science Foundation for his research on spinal cord injury regeneration.

Conclusion

Dr. Weitao Man is a highly accomplished neurosurgeon and researcher whose career reflects a profound commitment to advancing the field of neurosurgery. His combination of clinical expertise, cutting-edge research, and dedication to patient care makes him a leader in his field. Through his research on spinal cord injury, neurodegenerative diseases, and neuroregenerative therapies, Dr. Man continues to make significant contributions toward improving the outcomes for patients with neurological disorders. His work promises to shape the future of neurosurgery and regenerative medicine for years to come.

Publications Top Notes

  • Title: 3D Bioprinted Dynamic Bioactive Living Construct Enhances Mechanotransduction-Assisted Rapid Neural Network Self-Organization for Spinal Cord Injury Repair

    • Authors: J. Yang, K. Kim, Y. Liu, K. Yang, X. Wang

    • Year: 2025

  • Title: Electroacupuncture Ameliorated Locomotor Symptoms in MPTP-Induced Mice Model of Parkinson’s Disease by Regulating Autophagy via Nrf2 Signaling

    • Authors: J. Zhang, Z. Fu, F. Wen, X. Sun, Y. Huang

    • Year: 2025